Войти на сайт

Возможность продолжения антиагрегантной терапии после внутримозгового кровоизлияния


Р.А.-С. Салман, М.С. Деннис

Stroke Research Group, Division of Clinical Neurosciences, Centre for Clinical Brain Sciences, University of Edinburgh, Edinburgh, United Kingdom.
Ключевые слова: магнитно-резонансная томография, аспирин, внутримозговое кровоизлияние, ингибиторы аггрегации тромбоцитов

Подписка


Литература

  1. Baigent C., Blackwell L., Collins R., Emberson J., Godwin J, Peto R. Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomized trials. Lancet. 2009;373:1849–1860.
  2. Sung J.J., Lau J.Y., Ching J.Y., Wu J.C., Lee Y.T., Chiu P.W. Continuation of low-dose aspirin therapy in peptic ulcer bleeding: a randomized trial. Ann Intern Med. 2010;152:1–9.
  3. Flynn R.W., MacDonald T.M., Murray G.D., MacWalter R.S., Doney A.S. Prescribing antiplatelet medicine and subsequent events after intracerebral hemorrhage. Stroke. 2010;41:2606–2611.
  4. Biffi A., Halpin A., Towfighi A., Gilson A., Busl K., Rost N. Aspirin and recurrent intracerebral hemorrhage in cerebral amyloid angiopathy. Neurology. 2010;75:693–698.
  5. Chong B.H., Chan K.H., Pong V., Lau K.K., Chan Y.H., Zuo M.L. Use of aspirin in Chinese after recovery from primary intracranial hemorrhage. Thromb Haemost. 2012;107:241–247.
  6. Glasziou P., Chalmers I., Rawlins M., McCulloch P. When are randomized trials unnecessary? Picking signal from noise. BMJ. 2007;334:349–351.
  7. Pasquini M., Charidimou A., van Asch C.J., Baharoglu M.I., Samarasekera N., Werring D.J. Variation in restarting antithrombotic drugs at hospital discharge after intracerebral hemorrhage. Stroke. 2014;45:2643–2648.
  8. Faden R.R., Beauchamp T.L., Kass N.E. Informed consent, comparative effectiveness, and learning healthcare. N Engl J Med. 2014;370:766–768.


Похожие статьи

К содержанию номера

Бионика Медиа